Patients should understand that BPC-157 represents an off-label use of an unapproved substance and that established alternative treatments may exist depending on their condition
At RegenCore, we understand these challenges and offer safe, effective personalized regenerative therapies
Synergistic Potential with TB-500 : When combined with TB-500, BPC-157 demonstrates enhanced regenerative outcomes through complementary mechanismsBPC-157 stimulating angiogenesis and fibroblast proliferation, and TB-500 improving cellular migration and cytoskeletal repair
While BPC-157 can be injected or orally consumed, the latter route may be associated with more targeted effects on the GI tract
AOD-9604 directly targets fat tissue without affecting GH/IGF-1 axis, making it a more selective option for pure fat metabolism enhancement without hormonal changes
It cannot be legally marketed or sold as a treatment for GERD or any other condition